MARKET

EGRX

EGRX

Eagle Pharmaceut
NASDAQ
4.550
-0.220
-4.61%
After Hours: 4.550 0 0.00% 16:20 04/24 EDT
OPEN
4.770
PREV CLOSE
4.770
HIGH
4.860
LOW
4.441
VOLUME
95.22K
TURNOVER
0
52 WEEK HIGH
30.40
52 WEEK LOW
4.100
MARKET CAP
58.96M
P/E (TTM)
4.994
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at EGRX last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at EGRX last week (0408-0412)?
Weekly Report · 04/15 10:17
HROW, HCAT and EGRX are among after hour movers
On the Move HROW, HCAT and EGRX are among after hour movers. Eagle Pharmaceuticals (EGRX) is down 10%. Applied Optoelectronics (AAOI) and Harrow (HROW) are among the gainers.
Seeking Alpha · 04/12 21:05
Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays
TipRanks · 04/12 20:34
Eagle Pharmaceuticals receives notification of deficiency from Nasdaq
Healthcare Eagle Pharmaceuticals receives notification of deficiency from Nasdaq. ETEagle Pharmaceuticals, Inc. (EGRX) Stock is not in compliance with continued listing requirements. Nasdaq says company failed to timely file its annual report for fiscal year ended December 31, 2023.
Seeking Alpha · 04/12 20:25
EAGLE PHARMACEUTICALS ANNOUNCES RECEIPT OF NOTIFICATION OF DEFICIENCY FROM NASDAQ REGARDING REQUIREMENT TO TIMELY FILE ANNUAL REPORT ON FORM 10-K
Reuters · 04/12 20:05
Weekly Report: what happened at EGRX last week (0401-0405)?
Weekly Report · 04/08 10:20
Weekly Report: what happened at EGRX last week (0325-0329)?
Weekly Report · 04/01 10:19
More
About EGRX
Eagle Pharmaceuticals, Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. The Company is focused on developing medicines that result in improvements in patients' lives. The Company's commercialized products include vasopressin, PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, TREAKISYM (Japan), and BYFAVO and BARHEMSYS through its wholly owned subsidiary Acacia Pharma Inc. Its oncology and central nervous system (CNS)/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. The Company also has a research and development facility in Cambridge, Massachusetts. The Company has office space in Palm Beach Gardens, Florida and Indianapolis, Indiana. The Company’s subsidiaries include Eagle Biologics, Inc., Eagle Research Lab Limited, Acacia Pharma Group plc, Acacia Pharma Limited and Acacia Pharma Inc.

Webull offers Eagle Pharmaceuticals Inc stock information, including NASDAQ: EGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EGRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EGRX stock methods without spending real money on the virtual paper trading platform.